Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Researchers develop simple scoring system to predict risk of dementia in older diabetes patients

Researchers have developed a simple scoring system, based on a patient’s age, health issues, and education, which accurately predicts the risk of dementia in people aged over 60 with type 2 diabetes.

20 Aug 2013

D-Pharm announces promising results with drug candidates in models of HAT and malaria

D-Pharm Ltd., announced today on-line publication of promising results with its drug candidates, DP-460 and DP-b99, in models of human African trypanosomiasis (HAT) and malaria.

20 Aug 2013

Pathophysiological abnormalities in preclinical phase of AD may be detected using CSF or neuroimaging biomarkers

Both A- and tau pathology appear to be associated with default mode network integrity before clinical onset of Alzheimer disease (AD), according to a study by Liang Wang, M.D., and colleagues at Washington University in St. Louis, Missouri.

20 Aug 2013

Pilots who fly at high altitudes may be at increased risk for brain lesions

A new study suggests that pilots who fly at high altitudes may be at an increased risk for brain lesions. The study is published in the August 20, 2013, print issue of Neurology, the medical journal of the American Academy of Neurology.

20 Aug 2013

Researchers study connections between brain network damage and Alzheimer's disease

In patients with early Alzheimer's disease, disruptions in brain networks emerge about the same time as chemical markers of the disease appear in the spinal fluid, researchers at Washington University School of Medicine in St. Louis have shown.

20 Aug 2013

Copper enhances progression of Alzheimer's disease

Copper appears to be one of the main environmental factors that trigger the onset and enhance the progression of Alzheimer's disease by preventing the clearance and accelerating the accumulation of toxic proteins in the brain. That is the conclusion of a study appearing today in the journal Proceedings of the National Academy of Sciences.

20 Aug 2013

Medical decision making for family member of cognitively impaired patient is more complicated

Decision-making by a surrogate for a family member who is unable to make medical decisions is more complicated than decision-making by patients themselves, according to a study from the Regenstrief Institute, Indiana University Center for Aging Research and the Charles Warren Fairbanks Center for Medical Ethics of Indiana University Health.

19 Aug 2013

Scientists identify new therapeutic targets to inhibit progression of Alzheimer's disease

To stop the progression of Alzheimer's disease in the early stage, it is necessary to identify new therapeutic targets. Prof. Yunpeng Cao and team from the First Affiliated Hospital of China Medical University examined striatal-enriched phosphatase 61 expression in the brain tissues of Alzheimer's disease rats using in vivo and in vitro models, and analyzed the molecular mechanism by which striatal-enriched phosphatase 61 regulates N-methyl-D- aspartate receptor 2B transport.

17 Aug 2013

Kinetin stops the effects of Parkinson's disease on brain cells, say scientists

The active ingredient in an over-the-counter skin cream might do more than prevent wrinkles. Scientists have discovered that the drug, called kinetin, also slows or stops the effects of Parkinson's disease on brain cells.

16 Aug 2013

Novel potential biomarker present in CSF reveals signs of dementia decade before

A study published today reported the identification of what may be the earliest known biomarker associated with the risk of developing Alzheimer's disease (AD). The results suggest that this novel potential biomarker is present in cerebral spinal fluid (CSF) at least a decade before signs of dementia manifest.

16 Aug 2013

Study suggests that about 70% of total Alzheimer's risk is hereditary

Alzheimer's, and intervene to reduce the risk of the disease? We may be closer to that goal, thanks to a team at the University of Kentucky. Researchers affiliated with the UK Sanders-Brown Center on Aging have completed new work in Alzheimer's genetics; the research is detailed in a paper published today in the Journal of Neuroscience.

16 Aug 2013

Professor receives Task Force on Minority Issues in Gerontology Outstanding Mentorship Award

The Gerontological Society of America - the nation's largest interdisciplinary organization devoted to the field of aging - has chosen William E. Haley, PhD, of the University of South Florida as the 2013 recipient of the Task Force on Minority Issues in Gerontology Outstanding Mentorship Award.

16 Aug 2013

MOOCs courses offered by JHUSON concentrate on Dementia and TB

An aging population and an old health scourge are the driving forces behind two massive open online courses (MOOCs) being offered this fall by the Johns Hopkins University School of Nursing (JHUSON).

14 Aug 2013

NIH awards $17M to research projects to investigate emerging field of exRNA

The National Institutes of Health announced today it will award $17 million this year for 24 research projects designed to improve scientists' understanding of a newly discovered type of cell-to-cell communication based on extracellular (outside the cell) RNA, also called exRNA.

14 Aug 2013

Nine risk factors for YOD in late adolescence

A study of Swedish men suggests nine risk factors, most of which can be traced to adolescence, account for most cases of young-onset dementia (YOD) diagnosed before the age of 65 years, according to a report published by JAMA Internal Medicine, a JAMA Network publication.

13 Aug 2013

New research opens door for development of treatments capable of stopping Alzheimer's disease

New research just out in the journal Science Translational Medicine opens the door for the development of treatments capable of stopping Alzheimer's disease (AD) before its first symptoms, that is to say before any crucial damage occurs. In fact, if AD is a devastating disorder it is also an extremely slow one; it takes more than 10 years for the first symptoms to appear making this preclinical period (pre-symptoms) the ideal time to intervene.

13 Aug 2013

Cedars-Sinai launches Phase I clinical trial to study tolerability of immunization to treat Alzheimer's disease

Cedars-Sinai Medical Center has launched a Phase I clinical trial to study the safety and tolerability of an experimental immunization to treat Alzheimer's disease. The treatment is based on Copaxone (glatiramer acetate), a drug often prescribed to reduce the frequency of multiple sclerosis relapses.

13 Aug 2013

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Researchers develop simple scoring system to predict risk of dementia in older diabetes patients

D-Pharm announces promising results with drug candidates in models of HAT and malaria

Pathophysiological abnormalities in preclinical phase of AD may be detected using CSF or neuroimaging biomarkers

Pilots who fly at high altitudes may be at increased risk for brain lesions

Researchers study connections between brain network damage and Alzheimer's disease

Copper enhances progression of Alzheimer's disease

Medical decision making for family member of cognitively impaired patient is more complicated

Scientists identify new therapeutic targets to inhibit progression of Alzheimer's disease

Kinetin stops the effects of Parkinson's disease on brain cells, say scientists

Novel potential biomarker present in CSF reveals signs of dementia decade before

Study suggests that about 70% of total Alzheimer's risk is hereditary

Professor receives Task Force on Minority Issues in Gerontology Outstanding Mentorship Award

MOOCs courses offered by JHUSON concentrate on Dementia and TB

NIH awards $17M to research projects to investigate emerging field of exRNA

Nine risk factors for YOD in late adolescence

New research opens door for development of treatments capable of stopping Alzheimer's disease

Cedars-Sinai launches Phase I clinical trial to study tolerability of immunization to treat Alzheimer's disease

Simple tests to recognize ability of famous people may help doctors identify early dementia

QUM report helps manage antipsychotic medicine use in residential aged care facilities

Congress weighing changes to Medicare reimbursements for doctors

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Newsletters you may be interested in